i3 Drug Safety Biographies

John D. Seeger is a pharmacoepidemiologist who has been working with Ingenix/i3 Drug Safety since 2001 and has conducted numerous studies that have addressed regulatory drug safety issues involving a wide array of drugs and disease conditions, largely within an insurance claims environment. Dr. Seeger received a PharmD from the University of Arizona, a MPH from the University of Michigan, and a DrPH from the Harvard School of Public Health. Originally trained as a clinical pharmacist, Dr. Seeger spent three years on the faculty of the University of Illinois at Chicago where he also completed a residency in pharmacy practice. Dr. Seeger's research interest is in predictors of drug therapy and research methods that incorporate these predictors. He has worked extensively with propensity scores and related methods that seek to mitigate confounding by modeling drug therapy as a function of covariates, and he teaches a course on propensity scores at Harvard School of Public Health. He has authored or co-authored more than 30 articles in the peer-reviewed medical literature.